{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:26:36Z","timestamp":1777127196357,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Migraine is and continues to be a significant medical issue in older adults. Migraine can have different characteristics in older adults and specific diagnostic and treatment considerations need to be applied when managing headache and migraine in this population, which is increasing in both size and diversity. Contrary to widely held beliefs, migraine may not improve in older women following menopause and can have new onset in older age. The purpose of this review is to give an update on the diagnosis and treatment of episodic migraine in older adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>As the population ages, migraine in older adults will become a more significant public health issue. Migraine in older adults can present with different clinical symptoms than in a younger population and is primarily a diagnosis of exclusion in older adults. Migraine treatment considerations for older adults should include comorbidities and medication interactions. Recent findings suggest there are medications that should be avoided when treating seniors with migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>The purpose of this review is to give an update on the most important aspects regarding the diagnosis and treatment of headache and migraine in older adults. In addition, recommendations will be made concerning medications that need careful consideration when prescribing to seniors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11916-022-01029-7","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T10:21:12Z","timestamp":1649240472000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Episodic Migraine and Older Adults"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5463-2623","authenticated-orcid":false,"given":"Nina","family":"Riggins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"publisher","unstructured":"Wijeratne T, Tang HM, Crewther D, Crewther S. Prevalence of migraine in the elderly: a narrated review. Neuroepidemiology. 2019;52(1\u20132):104\u2013110. https:\/\/doi.org\/10.1159\/000494758. Epub 2019 Jan 9. PMID: 30625476. Article provides current review of migraine prevalence in population of older adults.","DOI":"10.1159\/000494758"},{"issue":"2","key":"1029_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1468-2982.2006.01250.x","volume":"27","author":"J Haan","year":"2007","unstructured":"Haan J, Hollander J, Ferrari MD. Migraine in the elderly: a review. Cephalalgia. 2007;27(2):97\u2013106. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01250.x.\u00a0PMID: 17257228.","journal-title":"Cephalalgia"},{"key":"1029_CR3","doi-asserted-by":"crossref","unstructured":"Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1):64\u20139. PMID: 1727198.","DOI":"10.1001\/jama.267.1.64"},{"issue":"4","key":"1029_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496\u2013505. https:\/\/doi.org\/10.1111\/head.13281. Epub 2018 Mar 12 PMID: 29527677.","journal-title":"Headache"},{"issue":"1","key":"1029_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/head.12482.Erratum.In:Headache.2015Feb;55(2):356","volume":"55","author":"RC Burch","year":"2015","unstructured":"Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21\u201334.\u00a0https:\/\/doi.org\/10.1111\/head.12482. Erratum. In: Headache. 2015 Feb;55(2):356.\u00a0PMID: 25600719.","journal-title":"Headache"},{"issue":"3","key":"1029_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jnnp.70.3.377.PMID:11181862;PMCID:PMC1737286","volume":"70","author":"M Prencipe","year":"2001","unstructured":"Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, Culasso F. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70(3):377\u201381. https:\/\/doi.org\/10.1136\/jnnp.70.3.377. PMID: 11181862; PMCID: PMC1737286.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1029_CR7","doi-asserted-by":"publisher","unstructured":"Feleppa M, Fucci S, Bigal ME.\u00a0Primary headaches in an elderly population seeking medical care for cognitive decline. Headache: The Journal of Head and Face Pain. 2017;57: 209\u2013216. https:\/\/doi.org\/10.1111\/head.13003.","DOI":"10.1111\/head.13003"},{"key":"1029_CR8","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Robblee J, Singh RH. Headache in the older population: causes, diagnoses, and treatments. Curr Pain Headache Rep. 2020;24:34. https:\/\/doi.org\/10.1007\/s11916-020-00866-8. This is an excellent updated review of different types of primary and secondary headaches in older adults.","DOI":"10.1007\/s11916-020-00866-8"},{"issue":"1","key":"1029_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10194-004-0066-9","volume":"5","author":"C Lisotto","year":"2004","unstructured":"Lisotto C, Mainardi F, Maggioni F, Dainese F, Zanchin G. Headache in the elderly: a clinical study. J Headache Pain. 2004;5(1):36\u201341. https:\/\/doi.org\/10.1007\/s10194-004-0066-9.","journal-title":"J Headache Pain"},{"issue":"4","key":"1029_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/head.13247","volume":"58","author":"P de Rijk","year":"2018","unstructured":"de Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache. 2018;58(4):525\u201333. https:\/\/doi.org\/10.1111\/head.13247. Epub 2017 Dec 13 PMID: 29235107.","journal-title":"Headache"},{"issue":"2","key":"1029_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.mayocp.2017.12.002","volume":"93","author":"AJ Starling","year":"2018","unstructured":"Starling AJ. Diagnosis and management of headache in older adults. Mayo Clin Proc. 2018;93(2):252\u201362. https:\/\/doi.org\/10.1016\/j.mayocp.2017.12.002.\u00a0PMID: 29406202.","journal-title":"Mayo Clin Proc"},{"key":"1029_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/B978-0-12-804766-8.00028-5","volume":"167","author":"RG Kaniecki","year":"2019","unstructured":"Kaniecki RG, Levin AD. Headache in the elderly. Handb Clin Neurol. 2019;167:511\u201328. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00028-5.\u00a0PMID: 31753152.","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"1029_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/01.STR.29.8.1539","volume":"29","author":"CA Wijman","year":"1998","unstructured":"Wijman CA, Wolf PA, Kase CS, Kelly-Hayes M, Beiser AS. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke. 1998;29(8):1539\u201343.","journal-title":"Stroke"},{"key":"1029_CR14","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Management of Headache in the Elderly (chapter 23, pages 290\u2013306) from the book \u201cHeadache\u201d Robbins MS, Grosberg BM and Lipton RB, eds. Published 19 July 2013: Wiley & sons. Print ISBN:9780470654729. Online ISBN:9781118678961. https:\/\/doi.org\/10.1002\/9781118678961.\u00a0This chapter provides great review of considerations for causes of secondary headache.","DOI":"10.1002\/9781118678961"},{"issue":"5","key":"1029_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1526-4610.1990.hed3005273.x","volume":"30","author":"G Solomon","year":"1990","unstructured":"Solomon G, Kunkel RJ, Frame J. Demographics of headache in elderly patients. Headache. 1990;30(5):273\u20136.","journal-title":"Headache"},{"key":"1029_CR16","unstructured":"Winkler A, True D. Giant cell arteritis: 2018 review. Mo Med. 2018;115(5):468\u2013470. PMID: 30385998; PMCID: PMC6205276."},{"key":"1029_CR17","doi-asserted-by":"publisher","unstructured":"Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983;26(10):1214\u20139. https:\/\/doi.org\/10.1002\/art.1780261007. PMID: 6626279.","DOI":"10.1002\/art.1780261007"},{"issue":"8","key":"1029_CR18","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/head.13600","volume":"59","author":"I Spanou","year":"2019","unstructured":"Spanou I, Bougea A, Liakakis G, Rizonaki K, Anagnostou E, Duntas L, Kararizou E. Relationship of migraine and tension-type headache with hypothyroidism: a literature review. Headache. 2019;59(8):1174\u201386. https:\/\/doi.org\/10.1111\/head.13600.\u00a0Epub 2019 Jul 16 PMID: 31310335.","journal-title":"Headache"},{"issue":"2","key":"1029_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/practneurol-2018-002045","volume":"19","author":"J Lazari","year":"2019","unstructured":"Lazari J, Money-Kyrle A, Wakerley BR. Cardiac cephalalgia: severe, non-exertional headache presenting as unstable angina. Pract Neurol. 2019;19(2):173\u20135.","journal-title":"Pract Neurol"},{"issue":"1","key":"1029_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0038-1677023","volume":"39","author":"L Filler","year":"2019","unstructured":"Filler L, Akhter M, Nimlos P. Evaluation and management of the emergency department headache. Semin Neurol. 2019;39(1):20\u20136. https:\/\/doi.org\/10.1055\/s-0038-1677023.\u00a0Epub 2019 Feb 11 PMID: 30743289.","journal-title":"Semin Neurol"},{"key":"1029_CR21","doi-asserted-by":"publisher","unstructured":"Spa\u0142ka J, K\u0119dzia K, Kuczy\u0144ski W, et al. Morning headache as an obstructive sleep apnea-related symptom among sleep clinic patients-a cross-section analysis. Brain Sci. 2020;10(1):57. Published 2020 Jan 19.\u00a0https:\/\/doi.org\/10.3390\/brainsci10010057.","DOI":"10.3390\/brainsci10010057"},{"issue":"5","key":"1029_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11916-019-0767-z","volume":"23","author":"KN Arca","year":"2019","unstructured":"Arca KN, Halker Singh RB. The hypertensive headache: a review. Curr Pain Headache Rep. 2019;23(5):30. https:\/\/doi.org\/10.1007\/s11916-019-0767-z.\u00a0PMID: 30874912.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1029_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/head.12875","volume":"57","author":"E Sousa Melo","year":"2017","unstructured":"Sousa Melo E, Carrilho Aguiar F, Sampaio Rocha-Filho PA. Dialysis headache: a narrative review. Headache. 2017;57(1):161\u20134. https:\/\/doi.org\/10.1111\/head.12875.\u00a0Epub 2016 Jun 28 PMID: 27349210.","journal-title":"Headache"},{"key":"1029_CR24","unstructured":"Gruver C, Guthmiller KB. Postherpetic neuralgia. [Updated 2020 Oct 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493198\/."},{"key":"1029_CR25","doi-asserted-by":"publisher","unstructured":"Sharma TL.\u00a0Common primary and secondary causes of headache in the elderly. Headache: The Journal of Head and Face Pain. 2018;58: 479\u2013484.\u00a0https:\/\/doi.org\/10.1111\/head.13252.","DOI":"10.1111\/head.13252"},{"issue":"5","key":"1029_CR26","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3390\/ijerph18052674.PMID:33799926;PMCID:PMC7967518","volume":"18","author":"C Monteiro","year":"2021","unstructured":"Monteiro C, Dias B, Vaz-Patto M. Headache as an adverse reaction to the use of medication in the elderly: a pharmacovigilance study. Int J Environ Res Public Health. 2021;18(5):2674. https:\/\/doi.org\/10.3390\/ijerph18052674. PMID: 33799926; PMCID: PMC7967518.","journal-title":"Int J Environ Res Public Health"},{"key":"1029_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/11315980-000000000-00000","volume":"27","author":"MS Robbins","year":"2010","unstructured":"Robbins MS, Lipton RB. Management of headache in the elderly. Drugs Aging. 2010;27:377\u201398. https:\/\/doi.org\/10.2165\/11315980-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"Suppl 2","key":"1029_CR28","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1007\/s10072-006-0590-2","volume":"27","author":"R De Simone","year":"2006","unstructured":"De Simone R, Marano E, Ranieri A, Bonavita V. Hypnic headache: an update. Neurol Sci. 2006;27(Suppl 2):S144\u20138. https:\/\/doi.org\/10.1007\/s10072-006-0590-2.\u00a0PMID: 16688619.","journal-title":"Neurol Sci"},{"key":"1029_CR29","doi-asserted-by":"crossref","unstructured":"ICHD-3 criteria for hypnic headache Criteria The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629\u2013808.","DOI":"10.1177\/0333102413485658"},{"key":"1029_CR30","doi-asserted-by":"publisher","unstructured":"Dissanayake KP, Wanniarachchi DP, Ranawaka UK. Case report of hypnic headache: a rare headache disorder with nocturnal symptoms. BMC Res Notes. 2017;10(1):318. Published 2017 Jul 25.\u00a0https:\/\/doi.org\/10.1186\/s13104-017-2641-6.","DOI":"10.1186\/s13104-017-2641-6"},{"issue":"8","key":"1029_CR31","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/head.12862","volume":"56","author":"AA Gelfand","year":"2016","unstructured":"Gelfand AA, Goadsby PJ. The role of melatonin in the treatment of primary headache disorders. Headache. 2016;56(8):1257\u201366. https:\/\/doi.org\/10.1111\/head.12862.","journal-title":"Headache"},{"issue":"1","key":"1029_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11940-011-0156-3","volume":"14","author":"HC Diener","year":"2012","unstructured":"Diener HC, Obermann M, Holle D. Hypnic headache: clinical course and treatment. Curr Treat Options Neurol. 2012;14(1):15\u201326. https:\/\/doi.org\/10.1007\/s11940-011-0156-3.\u00a0PMID: 22072057.","journal-title":"Curr Treat Options Neurol"},{"issue":"2","key":"1029_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1526-4610.2006.00343.x","volume":"46","author":"KM Martins","year":"2006","unstructured":"Martins KM, Bordini CA, Bigal ME, Speciali JG. Migraine in the elderly: a comparison with migraine in young adults. Headache. 2006;46(2):312\u20136. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00343.x.\u00a0PMID: 16492241.","journal-title":"Headache"},{"issue":"1","key":"1029_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-019-0985-0.Erratum.In:JHeadachePain.2019Jun19;20(1):71.PMID:30961531;PMCID:PMC6734460","volume":"20","author":"A Straube","year":"2019","unstructured":"Straube A, Andreou A. Primary headaches during lifespan. J Headache Pain. 2019;20(1):35. https:\/\/doi.org\/10.1186\/s10194-019-0985-0. Erratum. In: J Headache Pain.2019Jun19;20(1):71. PMID: 30961531; PMCID: PMC6734460.","journal-title":"J Headache Pain"},{"issue":"10","key":"1029_CR35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0333102414560635","volume":"35","author":"K Vongvaivanich","year":"2015","unstructured":"Vongvaivanich K, Lertakyamanee P, Silberstein SD, Dodick DW. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35(10):894\u2013911. https:\/\/doi.org\/10.1177\/0333102414560635.\u00a0Epub 2014 Dec 12 PMID: 25505036.","journal-title":"Cephalalgia"},{"issue":"1","key":"1029_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/head.12992","volume":"57","author":"JR Hascalovici","year":"2017","unstructured":"Hascalovici JR, Robbins MS. Peripheral nerve blocks for the treatment of headache in older adults: a retrospective study. Headache. 2017;57(1):80\u20136. https:\/\/doi.org\/10.1111\/head.12992.\u00a0Epub 2016 Nov 30 PMID: 27901275.","journal-title":"Headache"},{"key":"1029_CR37","doi-asserted-by":"publisher","unstructured":"\u2022 By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674\u2013694. https:\/\/doi.org\/10.1111\/jgs.15767. Epub 2019 Jan 29. PMID: 30693946. This is an important review of updated American Geriatrics Society guidance of medication use in older adults.","DOI":"10.1111\/jgs.15767"},{"key":"1029_CR38","unstructured":"Biondi DM, Saper JR. Geriatric headache. How to make the diagnosis and manage the pain. Geriatrics (Basel, Switzerland). 2000;55(12):40, 43\u20135, 48\u201350."},{"key":"1029_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11916-019-0789-6.Ariclecontainsinformationonrecentclinicaltrialsinmigrainetreatment","volume":"23","author":"S Mathew","year":"2019","unstructured":"Mathew S, Ailani J. Traditional and novel migraine therapy in the aging population. Curr Pain Headache Rep. 2019;23:42. https:\/\/doi.org\/10.1007\/s11916-019-0789-6. Aricle contains information on recent clinical trials in migraine treatment.","journal-title":"Curr Pain Headache Rep"},{"key":"1029_CR40","doi-asserted-by":"publisher","unstructured":"Burris JE. Pharmacologic approaches to geriatric pain management. Arch Phys Med Rehabil. 2004;85(7 Suppl 3):S45\u20139; quiz S50\u20131. https:\/\/doi.org\/10.1016\/j.apmr.2004.03.011. PMID: 15221725.","DOI":"10.1016\/j.apmr.2004.03.011"},{"key":"1029_CR41","doi-asserted-by":"publisher","unstructured":"Goadsby PJ, Wietecha LA, Dennehy EB, Kuca B, Case MG, Aurora SK, Gaul C (2019) Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain: J Neurol\u00a02019;142(7):1894\u20131904. https:\/\/doi.org\/10.1093\/brain\/awz134.","DOI":"10.1093\/brain\/awz134"},{"issue":"23","key":"1029_CR42","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","volume":"381","author":"DW Dodick","year":"2019","unstructured":"Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Ubrogepant for the treatment of migraine. N Engl J Med. 2019;381(23):2230\u201341. https:\/\/doi.org\/10.1056\/NEJMoa1813049.","journal-title":"N Engl J Med"},{"issue":"10268","key":"1029_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","volume":"397","author":"R Croop","year":"2021","unstructured":"Croop R, Lipton RB, Kudrow D, Stock DA, Kamen L, Conway CM, Stock EG, Coric V, Goadsby PJ. Oral rimegepant for preventive treatment of migraine: a phase 2\/3, randomised, double-blind, placebo-controlled trial. Lancet. 2021;397(10268):51\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(20)32544-7.","journal-title":"Lancet"},{"key":"1029_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mds.21854","volume":"23","author":"CD Esper","year":"2008","unstructured":"Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord. 2008;23:401\u20134. https:\/\/doi.org\/10.1002\/mds.21854.","journal-title":"Mov Disord"},{"key":"1029_CR45","doi-asserted-by":"publisher","unstructured":"David DJ, Gourion D. Antid\u00e9presseurs et tol\u00e9rance: d\u00e9terminants et prise en charge des principaux effets ind\u00e9sirables [Antidepressant and tolerance: determinants and management of major side effects]. Encephale. 2016;42(6):553\u2013561. French. https:\/\/doi.org\/10.1016\/j.encep.2016.05.006. Epub 2016 Jul 14. PMID: 27423475.","DOI":"10.1016\/j.encep.2016.05.006"},{"issue":"2","key":"1029_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/00002512-200320020-00005","volume":"20","author":"LJ Stephen","year":"2003","unstructured":"Stephen LJ. Drug treatment of epilepsy in elderly people: focus on valproic Acid. Drugs Aging. 2003;20(2):141\u201352. https:\/\/doi.org\/10.2165\/00002512-200320020-00005.\u00a0PMID: 12534314.","journal-title":"Drugs Aging"},{"key":"1029_CR47","doi-asserted-by":"publisher","unstructured":"Opie LH. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects. Am J Hypertens. 1997;10(5):565-77. https:\/\/doi.org\/10.1016\/s0895-7061(96)00508-0. PMID: 9160770.","DOI":"10.1016\/s0895-7061(96)00508-0"},{"issue":"4","key":"1029_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ncl.2019.07.003","volume":"37","author":"A P\u00e9rez-Mu\u00f1oz","year":"2019","unstructured":"P\u00e9rez-Mu\u00f1oz A, Buse DC, Andrasik F. Behavioral interventions for migraine. Neurol Clin. 2019;37(4):789\u2013813. https:\/\/doi.org\/10.1016\/j.ncl.2019.07.003.\u00a0Epub 2019 Aug 22 PMID: 31563233.","journal-title":"Neurol Clin"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-022-01029-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:27:18Z","timestamp":1649932038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-022-01029-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s11916-022-01029-7","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"4 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nina Riggins consulted for Gerson Lehrman Group, participated in compensated work with AcademicCME, principal investigator (PI) on research with Electrocore, uncompensated PI work on research with products of Theraspecs, Dolor technologies, Eli Lilly, uncompensated work on NeurologyLive Advisory Board and received compensation for editing NeurologyLive issue, Board member of Miles for Migraine. Annika Ehrlich serves on the speaker\u00a0bureau for Abbvie and Lilly pharmaceuticals, has received consulting fees from Allergan, and has served on an advisory boards for Currax and BDSI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}